Neuroma Injections to Treat Restless Legs Syndrome - RCT
Public ClinicalTrials.gov record NCT00656110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Placebo-Controlled Trial of Bilateral 3rd/4th Common Digital Foot Nerve Injections to Treat Restless Legs Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether, in a randomized, placebo-controlled trial, restless legs syndrome (RLS) can be caused by pinched and damaged foot nerves called neuromas.
Study identification
- NCT ID
- NCT00656110
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2008
- Primary completion
- Oct 31, 2009
- Completion
- Nov 30, 2009
- Last update posted
- Mar 9, 2009
2008 – 2009
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southeastern Foot Specialists | Charleston | South Carolina | 29414 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Restless Legs Syndrome trials
Other public records listing Restless Legs Syndrome. Sorted by last update posted; newest first. Not a recommendation.
- NCT06076499: A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS Active, not recruiting
- NCT05003648: Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy Active, not recruiting
- NCT06866132: Response to an Investigational Device in Patients With Restless Legs Syndrome Active, not recruiting
- NCT06481176: Blood Changes After Exercise in Restless Legs Syndrome Recruiting
- NCT06570941: Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00656110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2009 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00656110 live on ClinicalTrials.gov.